Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07461584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Memory Enhancement in Aging With Optimal Dosing

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: Early Phase 1 → not applicable
    • Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of May 1, 2026 to Jun 1, 2026
    v3
  2. Enrollment reduced: 400 → 240 participants
    • Start date: Mar 15, 2026 to May 1, 2026
    • Study description shortened, about 51 words
    • Study title shortened, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Trial Details
NCT Number NCT07461584
Lead Sponsor Boston University Charles River Campus
Conditions
(from sponsor)		 Aging, Noninvasive Brain Stimulation, Memory
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov